US Stock MarketDetailed Quotes

Pliant Therapeutics (PLRX)

Watchlist
  • 1.180
  • +0.020+1.72%
Close Jun 3 15:59 ET
  • 1.180
  • 0.0000.00%
Post 20:01 ET
73.07MMarket Cap-0.64P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pliant Therapeutics (PLRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
60.65%-19.23M
17.47%-128.34M
62.68%-17.79M
34.68%-21.08M
10.36%-40.6M
-61.42%-48.86M
-33.64%-155.5M
-89.87%-47.66M
10.91%-32.27M
-82.95%-45.3M
Net income from continuing operations
64.32%-20.04M
28.99%-149.34M
52.59%-23.58M
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
Operating gains losses
---94K
--1.78M
--1.83M
----
----
----
----
----
----
----
Depreciation and amortization
-41.07%264K
-20.19%1.7M
-20.31%365K
-18.05%436K
-28.14%447K
-12.67%448K
15.43%2.13M
-1.29%458K
18.75%532K
30.40%622K
Other non cash items
2.71%835K
-5.04%3.28M
2.10%828K
1.48%821K
-29.13%815K
19.38%813K
44.39%3.45M
45.60%811K
35.51%809K
83.41%1.15M
Change In working capital
-14.90%-4.87M
-275.37%-15.94M
75.08%-2.04M
-119.27%-2.75M
-304.21%-6.92M
-189.46%-4.23M
626.54%9.09M
-1,443.35%-8.18M
683.74%14.25M
-127.56%-1.71M
-Change in receivables
----
----
----
----
----
----
--0
--0
--0
--0
-Change in prepaid assets
73.27%1.72M
-46.13%2.54M
79.55%-209K
-85.62%780K
128.38%975K
-73.46%995K
226.29%4.72M
-572.37%-1.02M
405.86%5.43M
-157.76%-3.44M
-Change in payables and accrued expense
-28.10%-6.59M
-437.10%-17.65M
78.51%-1.52M
-132.92%-2.93M
-492.78%-8.06M
-482.03%-5.15M
-8.96%5.24M
-477.23%-7.06M
557.09%8.9M
-68.48%2.05M
-Change in other current assets
3,937.50%323K
200.00%43K
--0
--0
177.78%35K
--8K
---43K
97.82%-8K
-97.28%10K
---45K
-Change in other current liabilities
-251.65%-320K
-6.83%-876K
-236.56%-313K
-629.27%-598K
144.68%126K
74.93%-91K
70.15%-820K
87.48%-93K
87.72%-82K
58.53%-282K
Cash from discontinued investing activities
Operating cash flow
60.65%-19.23M
17.47%-128.34M
62.68%-17.79M
34.68%-21.08M
10.36%-40.6M
-61.42%-48.86M
-33.64%-155.5M
-89.87%-47.66M
10.91%-32.27M
-82.95%-45.3M
Investing cash flow
Cash flow from continuing investing activities
-105.93%-4.1M
-4.31%134.29M
-95.48%1.77M
-9.82%27.92M
231.59%35.49M
16.07%69.11M
210.49%140.34M
22.59%39.13M
-19.07%30.96M
146.57%10.7M
Net PPE purchase and sale
138.93%102K
94.31%-219K
99.52%-1K
117.41%156K
91.05%-112K
82.44%-262K
-317.81%-3.85M
-242.62%-209K
-853.19%-896K
-107.46%-1.25M
Net investment purchase and sale
-106.06%-4.2M
-6.71%134.51M
-95.50%1.77M
-12.84%27.77M
197.82%35.6M
13.66%69.38M
214.35%144.19M
23.01%39.34M
-16.93%31.86M
153.42%11.95M
Cash from discontinued investing activities
Investing cash flow
-105.93%-4.1M
-4.31%134.29M
-95.48%1.77M
-9.82%27.92M
231.59%35.49M
16.07%69.11M
210.49%140.34M
22.59%39.13M
-19.07%30.96M
146.57%10.7M
Financing cash flow
Cash flow from continuing financing activities
-85.14%74K
-237.12%-31.7M
-31,734.31%-32.27M
-86.74%72K
0
-97.71%498K
-91.58%23.12M
-53.42%102K
-22.32%543K
324.84%684K
Net issuance payments of debt
----
-262.06%-32.27M
-3,226,800.00%-32.27M
--0
--0
--0
--19.91M
--1K
--0
--0
Net common stock issuance
----
-82.23%570K
--0
----
----
----
-98.83%3.21M
-56.47%101K
-29.84%543K
-35.84%2.56M
Proceeds from stock option exercised by employees
-85.14%74K
----
----
----
--0
-73.50%498K
----
----
----
--684K
Cash from discontinued financing activities
Financing cash flow
-85.14%74K
-237.12%-31.7M
-31,734.31%-32.27M
-86.74%72K
--0
-97.71%498K
-91.58%23.12M
-53.42%102K
-22.32%543K
324.84%684K
Net cash flow
Beginning cash position
-35.42%46.93M
12.29%72.67M
17.41%95.21M
7.86%88.3M
-19.31%93.42M
12.29%72.67M
92.13%64.72M
40.60%81.1M
48.98%81.87M
12.93%115.78M
Current changes in cash
-212.08%-23.26M
-423.65%-25.74M
-472.94%-48.29M
997.66%6.91M
84.91%-5.12M
-59.37%20.75M
-74.37%7.95M
-219.75%-8.43M
-128.23%-770K
28.72%-33.91M
End cash Position
-74.66%23.67M
-35.42%46.93M
-35.42%46.93M
17.41%95.21M
7.86%88.3M
-19.31%93.42M
12.29%72.67M
12.29%72.67M
40.60%81.1M
48.98%81.87M
Free cash flow
60.86%-19.23M
19.23%-128.71M
62.84%-17.79M
36.44%-21.08M
12.53%-40.72M
-54.66%-49.13M
-35.87%-159.35M
-90.24%-47.87M
8.67%-33.17M
-83.53%-46.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 60.65%-19.23M17.47%-128.34M62.68%-17.79M34.68%-21.08M10.36%-40.6M-61.42%-48.86M-33.64%-155.5M-89.87%-47.66M10.91%-32.27M-82.95%-45.3M
Net income from continuing operations 64.32%-20.04M28.99%-149.34M52.59%-23.58M54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M
Operating gains losses ---94K--1.78M--1.83M----------------------------
Depreciation and amortization -41.07%264K-20.19%1.7M-20.31%365K-18.05%436K-28.14%447K-12.67%448K15.43%2.13M-1.29%458K18.75%532K30.40%622K
Other non cash items 2.71%835K-5.04%3.28M2.10%828K1.48%821K-29.13%815K19.38%813K44.39%3.45M45.60%811K35.51%809K83.41%1.15M
Change In working capital -14.90%-4.87M-275.37%-15.94M75.08%-2.04M-119.27%-2.75M-304.21%-6.92M-189.46%-4.23M626.54%9.09M-1,443.35%-8.18M683.74%14.25M-127.56%-1.71M
-Change in receivables --------------------------0--0--0--0
-Change in prepaid assets 73.27%1.72M-46.13%2.54M79.55%-209K-85.62%780K128.38%975K-73.46%995K226.29%4.72M-572.37%-1.02M405.86%5.43M-157.76%-3.44M
-Change in payables and accrued expense -28.10%-6.59M-437.10%-17.65M78.51%-1.52M-132.92%-2.93M-492.78%-8.06M-482.03%-5.15M-8.96%5.24M-477.23%-7.06M557.09%8.9M-68.48%2.05M
-Change in other current assets 3,937.50%323K200.00%43K--0--0177.78%35K--8K---43K97.82%-8K-97.28%10K---45K
-Change in other current liabilities -251.65%-320K-6.83%-876K-236.56%-313K-629.27%-598K144.68%126K74.93%-91K70.15%-820K87.48%-93K87.72%-82K58.53%-282K
Cash from discontinued investing activities
Operating cash flow 60.65%-19.23M17.47%-128.34M62.68%-17.79M34.68%-21.08M10.36%-40.6M-61.42%-48.86M-33.64%-155.5M-89.87%-47.66M10.91%-32.27M-82.95%-45.3M
Investing cash flow
Cash flow from continuing investing activities -105.93%-4.1M-4.31%134.29M-95.48%1.77M-9.82%27.92M231.59%35.49M16.07%69.11M210.49%140.34M22.59%39.13M-19.07%30.96M146.57%10.7M
Net PPE purchase and sale 138.93%102K94.31%-219K99.52%-1K117.41%156K91.05%-112K82.44%-262K-317.81%-3.85M-242.62%-209K-853.19%-896K-107.46%-1.25M
Net investment purchase and sale -106.06%-4.2M-6.71%134.51M-95.50%1.77M-12.84%27.77M197.82%35.6M13.66%69.38M214.35%144.19M23.01%39.34M-16.93%31.86M153.42%11.95M
Cash from discontinued investing activities
Investing cash flow -105.93%-4.1M-4.31%134.29M-95.48%1.77M-9.82%27.92M231.59%35.49M16.07%69.11M210.49%140.34M22.59%39.13M-19.07%30.96M146.57%10.7M
Financing cash flow
Cash flow from continuing financing activities -85.14%74K-237.12%-31.7M-31,734.31%-32.27M-86.74%72K0-97.71%498K-91.58%23.12M-53.42%102K-22.32%543K324.84%684K
Net issuance payments of debt -----262.06%-32.27M-3,226,800.00%-32.27M--0--0--0--19.91M--1K--0--0
Net common stock issuance -----82.23%570K--0-------------98.83%3.21M-56.47%101K-29.84%543K-35.84%2.56M
Proceeds from stock option exercised by employees -85.14%74K--------------0-73.50%498K--------------684K
Cash from discontinued financing activities
Financing cash flow -85.14%74K-237.12%-31.7M-31,734.31%-32.27M-86.74%72K--0-97.71%498K-91.58%23.12M-53.42%102K-22.32%543K324.84%684K
Net cash flow
Beginning cash position -35.42%46.93M12.29%72.67M17.41%95.21M7.86%88.3M-19.31%93.42M12.29%72.67M92.13%64.72M40.60%81.1M48.98%81.87M12.93%115.78M
Current changes in cash -212.08%-23.26M-423.65%-25.74M-472.94%-48.29M997.66%6.91M84.91%-5.12M-59.37%20.75M-74.37%7.95M-219.75%-8.43M-128.23%-770K28.72%-33.91M
End cash Position -74.66%23.67M-35.42%46.93M-35.42%46.93M17.41%95.21M7.86%88.3M-19.31%93.42M12.29%72.67M12.29%72.67M40.60%81.1M48.98%81.87M
Free cash flow 60.86%-19.23M19.23%-128.71M62.84%-17.79M36.44%-21.08M12.53%-40.72M-54.66%-49.13M-35.87%-159.35M-90.24%-47.87M8.67%-33.17M-83.53%-46.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.13%
Sample Name
Sample Code
 -0.46%
Sample Name
Sample Code
 -0.75%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
-1.72%
5
VanEck Oil Services ETF
OIH
-2.15%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.25%
Sample Name
Sample Code
 +16.32%
Sample Name
Sample Code
 +6.47%
4
MINISO
MNSO
+6.42%
5
XPeng
XPEV
+6.14%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -